Because dasatinib is associated with significant myelosuppression, clients that ingest greater than the encouraged dosage should be monitored closely for myelosuppression and obtain ideal supportive therapy.7 Long-term, accelerated or blast stage CML with resistance or intolerance to prior therapy including imatinib mesilate;[2] As mentioned over, therapy of CML with dasatinib https://caspofunginacetate00987.ivasdesign.com/51663946/details-fiction-and-asymmetric-dimethylarginine